Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS.

Autor: Arrieta-Bolaños E; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.; German Cancer Consortium, DKTK Partner Site Essen/Düsseldorf, Germany., van der Burg LLJ; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo, Norway., Robin M; BMT Unit, Saint-Louis Hospital, Paris, France., Salmenniemi U; HUCH Comprehensive Cancer Center, Helsinki, Finland., Kröger N; University Medical Center Hamburg, Hamburg, Germany., Yakoub-Agha I; CHU de Lille, Lille, France., Huynh A; CHU-Institut Universitaire du Cancer de Toulouse, Toulouse, France., Crawley C; Addenbrooke's Hospital, Cambridge, United Kingdom., Deconinck E; Hôpital Jean Minjoz, Besancon, France., Bulabois CE; CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France., Forcade E; CHU Bordeaux, Pessac, France., Tholouli E; Manchester Royal Infirmary, Manchester, United Kingdom., van der Hem JGK; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Balen P; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Hoogenboom JD; EBMT Leiden Study Unit, Leiden, The Netherlands., de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; DKMS Clinical Trials Unit, Dresden, Germany., Malard F; Hôpital Saint Antoine, Paris, France.; Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy., Ruggeri A; Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy., Fleischhauer K; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.; German Cancer Consortium, DKTK Partner Site Essen/Düsseldorf, Germany.

Publikováno v: Blood [Blood] 2024 Oct 17; Vol. 144 (16), pp. 1747-1751.

Allogeneic Serum Eye Drops: A Randomized Clinical Trial to Evaluate the Clinical Effectiveness of Two Drop Sizes.

Autor: Vermeulen C; Department of Product and Process Development, Sanquin Blood Bank, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands., van der Burg LLJ; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., van Geloven N; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Eggink CA; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands., Cheng YYY; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Nuijts RMMA; University Clinic for Ophthalmology, Maastricht, The Netherlands., Wisse RPL; Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands., van Luijk CM; Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands., Nieuwendaal C; Department of Ophthalmology, University Medical Center Amsterdam, Location AMC, Amsterdam, The Netherlands., Remeijer L; The Rotterdam Eye Hospital, Rotterdam, The Netherlands., van der Meer PF; Department of Product and Process Development, Sanquin Blood Bank, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands.; Department Hematology, Haga Teaching Hospital, The Hague, The Netherlands., de Korte D; Department of Product and Process Development, Sanquin Blood Bank, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands., Klei TRL; Department of Product and Process Development, Sanquin Blood Bank, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands. t.klei@sanquin.nl.

Publikováno v: Ophthalmology and therapy [Ophthalmol Ther] 2023 Dec; Vol. 12 (6), pp. 3347-3359. Date of Electronic Publication: 2023 Oct 16.